Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
RenovoRx (RNXT)
NASDAQ:RNXT
RenovoRx (RNXT) Stock Price & Analysis
24 Followers
RNXT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.50 - $5.75
Previous Close$1.9
Volume13.77K
Average Volume (3M)51.42K
Market Cap
$19.25M
Enterprise Value$15.55M
Total Cash (Recent Filing)$3.70M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.7
Beta1.10
Next Earnings
Aug 14, 2023EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.12
Shares Outstanding10,131,798
10 Day Avg. Volume20,050
30 Day Avg. Volume51,421
Standard Deviation0.28
R-Squared0.00002
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)5.91
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.22
Forecast
1Y Price Target
$9.00Price Target Upside383.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
RenovoRx News
Pre-EarningsRenovorx, Inc. (RNXT) Q4 Earnings Cheat Sheet
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RNXT FAQ
What was RenovoRx’s price range in the past 12 months?
RenovoRx lowest stock price was $1.50 and its highest was $5.75 in the past 12 months.
What is RenovoRx’s market cap?
Currently, no data Available
When is RenovoRx’s upcoming earnings report date?
RenovoRx’s upcoming earnings report date is Aug 14, 2023 which is in 75 days.
How were RenovoRx’s earnings last quarter?
RenovoRx released its earnings results on May 15, 2023. The company reported -$0.36 earnings per share for the quarter, missing the consensus estimate of -$0.215 by -$0.145.
Is RenovoRx overvalued?
According to Wall Street analysts RenovoRx’s price is currently Undervalued.
Does RenovoRx pay dividends?
RenovoRx does not currently pay dividends.
What is RenovoRx’s EPS estimate?
RenovoRx’s EPS estimate is -$0.29.
How many shares outstanding does RenovoRx have?
RenovoRx has 10,131,798 shares outstanding.
What happened to RenovoRx’s price movement after its last earnings report?
RenovoRx reported an EPS of -$0.36 in its last earnings report, missing expectations of -$0.215. Following the earnings report the stock price went up 10.945%.
Which hedge fund is a major shareholder of RenovoRx?
Currently, no hedge funds are holding shares in RNXT
---
RenovoRx Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.00%
12-Months-Change
Fundamentals
Return on Equity
-128.42%
Trailing 12-Months
Asset Growth
-67.30%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
RenovoRx
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.
---
Top 5 ETFs holding RNXT
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold RNXT. The ETFs are listed according to market value of RNXT within the ETF
---
Cellectar Biosciences
―
180 Life Sciences
―
Humanigen
―
Tempest Therapeutics
―
Skye Bioscience
―
---